25 October 2022>: Original Paper
Risk Factors for Polyomavirus, Cytomegalovirus, and Viruria Co-Infection for Follow-Up of Renal Transplant Patients
Ho Trung Hieu 1ABCDEFG* , Bui Tien Sy 2ACEFDOI: 10.12659/AOT.937771
Ann Transplant 2022; 27:e937771
Table 2 Characteristics of viruria infection in renal transplant recipients (n, %).
Characteristic | Total patients (n=81) | Patients in VS groups (n=25) | Patients in VC groups (n=56) | p-value |
---|---|---|---|---|
BK infection | 50 (61.73) | 10 (40.0) | 40 (71.43) | |
1 time | 12 (24.0) | 2 (20.0) | 10 (25.0) | |
Repeated | 38 (76.0) | 8 (80.0) | 30 (75.0) | |
JC infection | 46 (56.79) | 8 (32.0) | 38 (67.86) | |
1 time | 14 (30.43) | 2 (25.0) | 12 (31.58) | |
Repeated | 32 (69.57) | 6 (75.0) | 26 (68.42) | |
CMV infection | 55 (67.9) | 7 (28.0) | 48 (85.71) | |
1 time | 20 (36.36) | 3 (42.86) | 17 (35.42) | |
Repeated | 35 (63.64) | 4 (57.14) | 31 (64.58) | |
EBV infection | 7 (8.64) | – | 7 (12.5) | - |
1 time | 6 (85.71) | 6 (85.71) | ||
Repeated | 1 (14.29) | 1 (14.29) | ||
HSV infection | 2 (2.47) | – | 2 (3.57) | - |
1 time | 2 (100.0) | – | 2 (100.0) | - |
Repeated | – | – | ||
Time until viruria, mean±SD | 9.47±15.28 | 7.07±7.48 | 10.49±17.55 | >0.05 |
BK – BK polyomavirus; CMV – cytomegalovirus; EBV – Human Epstein-Barr virus; HSV – Herpes Simplex Virus; JC – JC polyomavirus. |